Literature DB >> 11239126

Psychophysiologic assessment of posttraumatic stress disorder in breast cancer patients.

R K Pitman1, D M Lanes, S K Williston, J L Guillaume, L J Metzger, G M Gehr, S P Orr.   

Abstract

The authors performed psychodiagnostic, psychometric, and psychophysiologic evaluations on 37 patients referred by local surgeons approximately 2 years after tissue diagnosis of Stage I to III breast cancer. The Clinician-Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS) was used to classify patients into the following groups: "Current PTSD" (n = 5) "Past PTSD" (n = 7), and "Never had PTSD" (n = 25). Individualized "scripts" portraying personal life events were tape recorded and played back to the patients in the laboratory. Current PTSD patients showed significantly higher heart rate, skin conductance, and corrugator electromyogram responses during imagery of their personal breast cancer experiences than Past and Never patients. Physiologic responses were significantly and positively correlated with CAPS scores. These results provide psychophysiologic support for the proposition that a diagnosis of with a life-threatening illness can cause PTSD.

Entities:  

Mesh:

Year:  2001        PMID: 11239126     DOI: 10.1176/appi.psy.42.2.133

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  20 in total

1.  Posttraumatic stress disorder (PTSD) in survivors of Hodgkin's lymphoma: prevalence of PTSD and partial PTSD compared with sibling controls.

Authors:  Veronica Sanchez Varela; Andrea Ng; Peter Mauch; Christopher J Recklitis
Journal:  Psychooncology       Date:  2011-12-08       Impact factor: 3.894

2.  A longitudinal examination of couples' coping strategies as predictors of adjustment to breast cancer.

Authors:  Lia M Kraemer; Annette L Stanton; Beth E Meyerowitz; Julia H Rowland; Patricia A Ganz
Journal:  J Fam Psychol       Date:  2011-09-19

3.  Symptoms of posttraumatic stress disorder among hospitalized patients with cancer.

Authors:  Ryan D Nipp; Areej El-Jawahri; Sara M D'Arpino; Andy Chan; Charn-Xin Fuh; P Connor Johnson; Daniel E Lage; Risa L Wong; William F Pirl; Lara Traeger; Barbara J Cashavelly; Vicki A Jackson; David P Ryan; Ephraim P Hochberg; Jennifer S Temel; Joseph A Greer
Journal:  Cancer       Date:  2018-06-15       Impact factor: 6.860

4.  Post-traumatic stress outcomes in non-Hodgkin's lymphoma survivors.

Authors:  Sophia K Smith; Sheryl Zimmerman; Christianna S Williams; John S Preisser; Elizabeth C Clipp
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

5.  Aversive imagery in posttraumatic stress disorder: trauma recurrence, comorbidity, and physiological reactivity.

Authors:  Lisa M McTeague; Peter J Lang; Marie-Claude Laplante; Bruce N Cuthbert; Joshua R Shumen; Margaret M Bradley
Journal:  Biol Psychiatry       Date:  2009-10-28       Impact factor: 13.382

6.  PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors.

Authors:  Rebecca A Shelby; Deanna M Golden-Kreutz; Barbara L Andersen
Journal:  J Trauma Stress       Date:  2008-04

7.  Trauma-related reactivity and regulation of emotion: associations with posttraumatic stress symptoms.

Authors:  Christal L Badour; Matthew T Feldner
Journal:  J Behav Ther Exp Psychiatry       Date:  2012-08-10

8.  Veteran perceptions of virtual reality to assess and treat posttraumatic stress disorder.

Authors:  Teresa L Kramer; Patricia E Savary; Jeffrey M Pyne; Timothy A Kimbrell; Susan M Jegley
Journal:  Cyberpsychol Behav Soc Netw       Date:  2013-04

9.  Paradoxical olfactory function in combat veterans: The role of PTSD and odor factors.

Authors:  Allison K Wilkerson; Thomas W Uhde; Kimberly Leslie; W Connor Freeman; Steven D LaRowe; Aicko Schumann; Bernadette M Cortese
Journal:  Mil Psychol       Date:  2018-04-04

10.  Post-traumatic stress symptoms in long-term non-Hodgkin's lymphoma survivors: does time heal?

Authors:  Sophia K Smith; Sheryl Zimmerman; Christianna S Williams; Habtamu Benecha; Amy P Abernethy; Deborah K Mayer; Lloyd J Edwards; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.